Literature DB >> 20146070

Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy.

Peter Reilich1, Nicolai Schramm, Benedikt Schoser, Peter Schneiderat, Nicola Strigl-Pill, Josef Müller-Höcker, Wolfram Kress, Andreas Ferbert, Sabine Rudnik-Schöneborn, Johannes Noth, Hanns Lochmüller, Joachim Weis, Maggie C Walter.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common muscular dystrophy and usually follows an autosomal dominant trait. Clinically, FSHD affects facial muscles and proximal upper limb and girdle muscles, but may present with variable clinical phenotypes even within the same family. Most genetically confirmed FSHD patients exhibit unspecific morphological signs of a degenerative myopathy. We report on five unrelated patients who carried the pathogenic FSHD mutation on chromosome 4q35. Muscle biopsies revealed numerous rimmed vacuoles and filamentous cytoplasmic inclusions in all cases. Clinically, the patients suffered from weakness and atrophy predominantly of the lower limb muscles. In conclusion, we suggest considering FSHD in the differential diagnosis of adult-onset distal myopathies with rimmed vacuoles.

Entities:  

Mesh:

Year:  2010        PMID: 20146070     DOI: 10.1007/s00415-010-5471-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

1.  Poly-Hill sign in facioscapulohumeral dystrophy.

Authors:  Sunil Pradhan
Journal:  Muscle Nerve       Date:  2002-05       Impact factor: 3.217

2.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.

Authors:  Richard J F L Lemmers; Mariëlle Wohlgemuth; Rune R Frants; George W Padberg; Eva Morava; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-10-04       Impact factor: 11.025

3.  Cardiac involvement in facioscapulohumeral muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger; Gerhard Meng
Journal:  Cardiology       Date:  2004-11-12       Impact factor: 1.869

4.  Significance of Beevor's sign in facioscapulohumeral dystrophy and other neuromuscular diseases.

Authors:  N Shahrizaila; A J Wills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

5.  Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.

Authors:  David B Olsen; Peter Gideon; Tina Dysgaard Jeppesen; John Vissing
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

6.  Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease.

Authors:  D M Slipetz; J R Aprille; P R Goodyer; R Rozen
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

7.  FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.

Authors:  K J Felice; W A North; S A Moore; K D Mathews
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

8.  An inherited 4q35-EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulohumeral muscular dystrophy (FSHD).

Authors:  K Busse; J Köhler; K Stegmann; D Pongratz; M C Koch; H Schreiber
Journal:  Neuromuscul Disord       Date:  2000-03       Impact factor: 4.296

9.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

10.  Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy.

Authors:  M Funakoshi; K Goto; K Arahata
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  12 in total

1.  [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

Authors:  B Jordan; C Müller-Reible; S Zierz
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

2.  Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.

Authors:  J U Regula; L Jestaedt; F Jende; A Bartsch; H-M Meinck; M-A Weber
Journal:  Clin Neuroradiol       Date:  2015-04-10       Impact factor: 3.649

3.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

4.  Neuromuscular disorders and 2010: recent advances.

Authors:  Anna Sarkozy; Hanns Lochmüller
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

5.  Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.

Authors:  Isabella Scionti; Francesca Greco; Giulia Ricci; Monica Govi; Patricia Arashiro; Liliana Vercelli; Angela Berardinelli; Corrado Angelini; Giovanni Antonini; Michelangelo Cao; Antonio Di Muzio; Maurizio Moggio; Lucia Morandi; Enzo Ricci; Carmelo Rodolico; Lucia Ruggiero; Lucio Santoro; Gabriele Siciliano; Giuliano Tomelleri; Carlo Pietro Trevisan; Giuliana Galluzzi; Woodring Wright; Mayana Zatz; Rossella Tupler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

6.  Muscular dystrophies at different ages: metabolic and endocrine alterations.

Authors:  Oriana Del Rocío Cruz Guzmán; Ana Laura Chávez García; Maricela Rodríguez-Cruz
Journal:  Int J Endocrinol       Date:  2012-06-03       Impact factor: 3.257

7.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

8.  Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice.

Authors:  Sachchida N Pandey; Jennifer Cabotage; Rongye Shi; Manjusha Dixit; Margret Sutherland; Jian Liu; Stephanie Muger; Scott Q Harper; Kanneboyina Nagaraju; Yi-Wen Chen
Journal:  Biol Open       Date:  2012-05-25       Impact factor: 2.422

9.  Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes.

Authors:  Giulia Ricci; Isabella Scionti; Greta Alì; Leda Volpi; Virna Zampa; Marina Fanin; Corrado Angelini; Luisa Politano; Rossella Tupler; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2012-01-14       Impact factor: 4.296

10.  Facioscapulohumeral muscular dystrophy and Charcot-Marie-Tooth neuropathy 1A - evidence for "double trouble" overlapping syndromes.

Authors:  Olivia Schreiber; Peter Schneiderat; Wolfram Kress; Bernd Rautenstrauss; Jan Senderek; Benedikt Schoser; Maggie C Walter
Journal:  BMC Med Genet       Date:  2013-09-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.